-
Griezmann double earns Atletico battling win over Levante
-
Title-leader Norris grabs Sao Paulo Grand Prix pole
-
Djokovic edges Musetti to win 101st career title in Athens
-
Rybakina downs world No.1 Sabalenka to win WTA Finals
-
McKenzie ends Scotland dream of first win over New Zealand
-
McKenzie stars as New Zealand inflict heartbreak upon Scotland
-
De Ligt rescues Man Utd in Spurs draw, Arsenal aim to extend lead
-
Kane saves Bayern but record streak ends at Union
-
Bolivia's new president takes over, inherits economic mess
-
Edwards set for Wolves job after Middlesbrough allow talks
-
COP30: Indigenous peoples vital to humanity's future, Brazilian minister tells AFP
-
Marquez wins Portuguese MotoGP sprint race
-
Saim, Abrar star in Pakistan's ODI series win over South Africa
-
Norris extends title lead in Sao Paulo GP sprint after Piastri spin
-
Man Utd have room to 'grow', says Amorim after Spurs setback
-
Tornado kills six, wrecks town in Brazil
-
Norris wins Sao Paulo GP sprint, Piastri spins out
-
Ireland scramble to scrappy win over Japan
-
De Ligt rescues draw for Man Utd after Tottenham turnaround
-
Israel identifies latest hostage body, as families await five more
-
England's Rai takes one-shot lead into Abu Dhabi final round
-
Tornado kills five, injures more than 400 in Brazil
-
UPS, FedEx ground MD-11 cargo planes after deadly crash
-
Luis Enrique not rushing to recruit despite key PSG trio's absence
-
Flick demands more Barca 'fight' amid injury crisis
-
Israel names latest hostage body, as families await five more
-
Title-chasing Evans cuts gap on Ogier at Rally Japan
-
Russian attack hits Ukraine energy infrastructure: Kyiv
-
Kagiyama tunes up for Olympics with NHK Trophy win
-
Indonesia probes student after nearly 100 hurt in school blasts
-
UPS grounds its MD-11 cargo planes after deadly crash
-
Taliban govt says Pakistan ceasefire to hold, despite talks failing
-
Trump says no US officials to attend G20 in South Africa
-
Philippines halts search for typhoon dead as huge new storm nears
-
Bucks launch NBA Cup title defense with win over Bulls
-
Chinese ship scouts deep-ocean floor in South Pacific
-
Taiwan badminton star Tai Tzu-ying announces retirement
-
New York City beat Charlotte 3-1 to advance in MLS Cup playoffs
-
'Almost every day': Japan battles spike in bear attacks
-
MLS Revolution name Mitrovic as new head coach
-
Trump gives Hungary's Orban one-year Russia oil sanctions reprieve
-
Owners of collapsed Dominican nightclub formally charged
-
US accuses Iran in plot to kill Israeli ambassador in Mexico
-
Watch the Marijuana Federal Action, Not the Speak: President Trump's Cannabis Decision Soon
-
New to The Street to Broadcast Show Number 698 on Bloomberg - Saturday, November 8, 2025, at 6:30 PM EST
-
Quanta SLS Capital Group - SLS-Covered Notes Backed by A/AA-Rated Insurance for Project Funding
-
New Zealand 'Once Were Warriors' director Tamahori dies
-
Hungary's Orban wins Russian oil sanctions exemption from Trump
-
More than 1,000 flights cut in US shutdown fallout
-
Turkey issues genocide arrest warrant against Netanyahu
Animal testing put to the test in Swiss vote
Switzerland goes to the polls Sunday to decide whether animal and human testing should be banned -- a proposal that has triggered an outcry in a country heavily reliant on big pharma.
Opinions suggest that the proposal by animal rights defenders is highly unlikely to pass.
But if it did, "Switzerland would be the only country internationally with such a ban," said Yves Fluckiger, president of the Swiss universities lobby group.
Researchers insist that medical progress is impossible without experimentation.
At the University of Geneva, Patrycja Nowak-Sliwinska, head of the molecular pharmacology laboratory, unveils her cell incubator where intestinal organoids from cancer patients are being cultivated.
These structures, made up of cells, make it possible to test a large number of potential treatments.
"With the in vitro model, we try to find promising candidates" -- and only the latter would then be tested on animals, said Nowak-Sliwinska, who received a prize rewarding researchers who work to replace animals with other methods.
But even she said it would be impossible to do all the research without animal experimentation and clinical trials.
This is why the university's Faculty of Medicine has an animal facility in the basement housing some 25,000 animals -- mostly mice and rats.
- Strict protocols -
Inside, Professor Doron Merkler conducts research to find a treatment for a form of multiple sclerosis.
The research could not advance without using mice, into which he injects modified cells to observe how the disease affects the nervous system.
The mouse he is working on is showing symptoms: instability, difficulty moving, and partial paralysis of the limbs.
The experiments are framed by a strict protocol regarding their degree of severity, and animal keepers are trained to detect when an animal is not well.
"If no veterinary care can be provided to the animal, we can decide with the researcher to sacrifice it," said Pierre Bonnaventure, head of animal facilities at the faculty.
In Switzerland, researchers seeking to use live animals must make a formal request, establish that there is no alternative method available and that the conditions imposed on the animals will be as light as possible.
The number of animals used has consequently fallen sharply, from nearly two million per year in the early 1980s to around 560,000.
Some 20,000 animals a year undergo severe interventions, such as the implantation of a tumour, according to federal authorities.
- Proposal 'goes too far' -
Under Switzerland's direct democracy system, campaigners collected enough signatures to trigger a popular vote.
The proposal would outlaw experiments not only on animals but on humans too, as well as ban the importation of new drugs developed through such means.
"Animal experiments should be considered a crime," Renato Werndli, a doctor among those who launched the initiative, told AFP.
All the major political parties in Switzerland are against the proposal.
For the government, the ban "goes too far" and would have "serious consequences for health" -- and also for the economy, in a country where the chemical and pharmaceutical sector represents just over half of all exports.
Interpharma, the Swiss pharmaceutical industry's lobby group, warned that in the event of a ban, "the institutions and companies concerned would be forced to relocate their activities abroad".
Switzerland has already rejected three initiatives on the subject -- in 1985 (70 percent), 1992 (56 percent) and 1993 (72 percent) -- and is expected to do likewise this time.
But it remains to be seen whether the majority will be as big, in a society where animal welfare has grown in importance.
For Samia Hurst, a bioethicist at the University of Geneva, the new initiative commits "a fairly frequent mistake, which is to target biomedical research".
However, she told AFP: "Animal experimentation, among the various uses that humanity makes of other species, is both the most closely monitored and undoubtedly the most justified."
O.Norris--AMWN